APO Research
Talk to an analyst

APO RESEARCH · REPORT

Percutaneous Coronary Intervention (PCI) Treatment Instruments

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Outlook and Growth Opportunities 2026

25 December 2025218 pages

Choose your research edition.

Industry ResearchPercutaneous Coronary Intervention (PCI) Treatment Instruments Industry Research Report 2026141 pages · $2,950 USDIndustry Growth & TrendsGlobal Percutaneous Coronary Intervention (PCI) Treatment Instruments Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Percutaneous Coronary Intervention (PCI) Treatment Instruments Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Outlook and Growth Opportunities 2026218 pages · $4,250 USDMarket Analysis & ForecastGlobal Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Analysis and Forecast 2026-2032215 pages · $4,950 USD

Market perspective

The global Percutaneous Coronary Intervention (PCI) Treatment Instruments market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Percutaneous Coronary Intervention (PCI) Treatment Instruments is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Percutaneous Coronary Intervention (PCI) Treatment Instruments is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Percutaneous Coronary Intervention (PCI) Treatment Instruments is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Percutaneous Coronary Intervention (PCI) Treatment Instruments market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Percutaneous Coronary Intervention (PCI) Treatment Instruments market include Medtronic, OrbusNeich Medical Company, MicroPort Scientific Corporation, Suzhou Innomed Medical Device, Shunmei Medical, Shanghai INT Medical Instruments, Lepu Medical Technology, APT Medical and BrosMed Medical, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Percutaneous Coronary Intervention (PCI) Treatment Instruments market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Percutaneous Coronary Intervention (PCI) Treatment Instruments and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Percutaneous Coronary Intervention (PCI) Treatment Instruments revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Percutaneous Coronary Intervention (PCI) Treatment Instruments market.

Percutaneous Coronary Intervention (PCI) Treatment Instruments Segment by Company

Medtronic

OrbusNeich Medical Company

MicroPort Scientific Corporation

Suzhou Innomed Medical Device

Shunmei Medical

Shanghai INT Medical Instruments

Lepu Medical Technology

APT Medical

BrosMed Medical

Terumo Corporation

QualiMe

Merit Medical

Curatia Medical

Cordis

Cardionovum

Boston Scientific

ASAHI INTECC

Abbott

Zhejiang Barty Medical Technology

Shenzhen MicroApproach Medical Technology

Beijing Demax Medical Technology

JW Medical Systems

SINOMED

Kinhely Bio-Tech

Shandong Huaan Biotechnology

Blue Sail Medical

Shanghai Bio-heart Biological Technology

Percutaneous Coronary Intervention (PCI) Treatment Instruments Segment by Type

Coronary Pathway Assistive Instruments

Interventional Treatment Instruments

Percutaneous Coronary Intervention (PCI) Treatment Instruments Segment by Application

Hospital

Clinic

Others

Percutaneous Coronary Intervention (PCI) Treatment Instruments Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Percutaneous Coronary Intervention (PCI) Treatment Instruments status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Percutaneous Coronary Intervention (PCI) Treatment Instruments key companies, revenue, market share, and recent developments.

3. To split the Percutaneous Coronary Intervention (PCI) Treatment Instruments breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Percutaneous Coronary Intervention (PCI) Treatment Instruments market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Percutaneous Coronary Intervention (PCI) Treatment Instruments significant trends, drivers, influence factors in global and regions.

6. To analyze Percutaneous Coronary Intervention (PCI) Treatment Instruments competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Percutaneous Coronary Intervention (PCI) Treatment Instruments market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Percutaneous Coronary Intervention (PCI) Treatment Instruments and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Percutaneous Coronary Intervention (PCI) Treatment Instruments.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Percutaneous Coronary Intervention (PCI) Treatment Instruments industry.

Chapter 3: Detailed analysis of Percutaneous Coronary Intervention (PCI) Treatment Instruments company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Percutaneous Coronary Intervention (PCI) Treatment Instruments in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Percutaneous Coronary Intervention (PCI) Treatment Instruments in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Percutaneous Coronary Intervention (PCI) Treatment Instruments Industry Trends Table 2. Percutaneous Coronary Intervention (PCI) Treatment Instruments Industry Drivers Table 3. Percutaneous Coronary Intervention (PCI) Treatment Instruments Industry Opportunities and Challenges Table 4. Percutaneous Coronary Intervention (PCI) Treatment Instruments Industry Restraints Table 5. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue Share by Company (2021-2026) Table 7. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Key Company Manufacturing Base & Headquarters Table 9. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Company, Product Type & Application Table 10. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Coronary Pathway Assistive Instruments Table 15. Significant Companies of Interventional Treatment Instruments Table 16. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type (2021-2026) Table 20. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospital Table 22. Significant Companies of Clinic Table 23. Significant Companies of Others Table 24. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application (2021-2026) Table 28. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application (2027-2032) Table 29. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Region (2021-2026) Table 32. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Region (2027-2032) Table 34. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Market Share by Country (2021-2026) Table 37. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Market Share by Country (2027-2032) Table 39. Medtronic Company Information Table 40. Medtronic Business Overview Table 41. Medtronic Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Medtronic Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 43. Medtronic Recent Development Table 44. OrbusNeich Medical Company Company Information Table 45. OrbusNeich Medical Company Business Overview Table 46. OrbusNeich Medical Company Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. OrbusNeich Medical Company Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 48. OrbusNeich Medical Company Recent Development Table 49. MicroPort Scientific Corporation Company Information Table 50. MicroPort Scientific Corporation Business Overview Table 51. MicroPort Scientific Corporation Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. MicroPort Scientific Corporation Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 53. MicroPort Scientific Corporation Recent Development Table 54. Suzhou Innomed Medical Device Company Information Table 55. Suzhou Innomed Medical Device Business Overview Table 56. Suzhou Innomed Medical Device Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Suzhou Innomed Medical Device Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 58. Suzhou Innomed Medical Device Recent Development Table 59. Shunmei Medical Company Information Table 60. Shunmei Medical Business Overview Table 61. Shunmei Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Shunmei Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 63. Shunmei Medical Recent Development Table 64. Shanghai INT Medical Instruments Company Information Table 65. Shanghai INT Medical Instruments Business Overview Table 66. Shanghai INT Medical Instruments Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Shanghai INT Medical Instruments Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 68. Shanghai INT Medical Instruments Recent Development Table 69. Lepu Medical Technology Company Information Table 70. Lepu Medical Technology Business Overview Table 71. Lepu Medical Technology Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Lepu Medical Technology Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 73. Lepu Medical Technology Recent Development Table 74. APT Medical Company Information Table 75. APT Medical Business Overview Table 76. APT Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. APT Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 78. APT Medical Recent Development Table 79. BrosMed Medical Company Information Table 80. BrosMed Medical Business Overview Table 81. BrosMed Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. BrosMed Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 83. BrosMed Medical Recent Development Table 84. Terumo Corporation Company Information Table 85. Terumo Corporation Business Overview Table 86. Terumo Corporation Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Terumo Corporation Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 88. Terumo Corporation Recent Development Table 89. QualiMe Company Information Table 90. QualiMe Business Overview Table 91. QualiMe Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. QualiMe Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 93. QualiMe Recent Development Table 94. Merit Medical Company Information Table 95. Merit Medical Business Overview Table 96. Merit Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Merit Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 98. Merit Medical Recent Development Table 99. Curatia Medical Company Information Table 100. Curatia Medical Business Overview Table 101. Curatia Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Curatia Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 103. Curatia Medical Recent Development Table 104. Cordis Company Information Table 105. Cordis Business Overview Table 106. Cordis Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Cordis Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 108. Cordis Recent Development Table 109. Cardionovum Company Information Table 110. Cardionovum Business Overview Table 111. Cardionovum Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Cardionovum Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 113. Cardionovum Recent Development Table 114. Boston Scientific Company Information Table 115. Boston Scientific Business Overview Table 116. Boston Scientific Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Boston Scientific Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 118. Boston Scientific Recent Development Table 119. ASAHI INTECC Company Information Table 120. ASAHI INTECC Business Overview Table 121. ASAHI INTECC Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. ASAHI INTECC Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 123. ASAHI INTECC Recent Development Table 124. Abbott Company Information Table 125. Abbott Business Overview Table 126. Abbott Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Abbott Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 128. Abbott Recent Development Table 129. Zhejiang Barty Medical Technology Company Information Table 130. Zhejiang Barty Medical Technology Business Overview Table 131. Zhejiang Barty Medical Technology Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Zhejiang Barty Medical Technology Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 133. Zhejiang Barty Medical Technology Recent Development Table 134. Shenzhen MicroApproach Medical Technology Company Information Table 135. Shenzhen MicroApproach Medical Technology Business Overview Table 136. Shenzhen MicroApproach Medical Technology Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Shenzhen MicroApproach Medical Technology Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 138. Shenzhen MicroApproach Medical Technology Recent Development Table 139. Beijing Demax Medical Technology Company Information Table 140. Beijing Demax Medical Technology Business Overview Table 141. Beijing Demax Medical Technology Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Beijing Demax Medical Technology Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 143. Beijing Demax Medical Technology Recent Development Table 144. JW Medical Systems Company Information Table 145. JW Medical Systems Business Overview Table 146. JW Medical Systems Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. JW Medical Systems Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 148. JW Medical Systems Recent Development Table 149. SINOMED Company Information Table 150. SINOMED Business Overview Table 151. SINOMED Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 152. SINOMED Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 153. SINOMED Recent Development Table 154. Kinhely Bio-Tech Company Information Table 155. Kinhely Bio-Tech Business Overview Table 156. Kinhely Bio-Tech Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 157. Kinhely Bio-Tech Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 158. Kinhely Bio-Tech Recent Development Table 159. Shandong Huaan Biotechnology Company Information Table 160. Shandong Huaan Biotechnology Business Overview Table 161. Shandong Huaan Biotechnology Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 162. Shandong Huaan Biotechnology Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 163. Shandong Huaan Biotechnology Recent Development Table 164. Blue Sail Medical Company Information Table 165. Blue Sail Medical Business Overview Table 166. Blue Sail Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 167. Blue Sail Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 168. Blue Sail Medical Recent Development Table 169. Shanghai Bio-heart Biological Technology Company Information Table 170. Shanghai Bio-heart Biological Technology Business Overview Table 171. Shanghai Bio-heart Biological Technology Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 172. Shanghai Bio-heart Biological Technology Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 173. Shanghai Bio-heart Biological Technology Recent Development Table 174. Research Programs/Design for This Report Table 175. Authors List of This Report Table 176. Secondary Sources Table 177. Primary Sources List of Figures Figure 1. Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Image Figure 2. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size (2021-2032) & (US$ Million) Figure 4. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Coronary Pathway Assistive Instruments Image Figure 8. Interventional Treatment Instruments Image Figure 9. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type (2021-2032) Figure 12. Hospital Image Figure 13. Clinic Image Figure 14. Others Image Figure 15. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application (2021-2032) Figure 18. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value (2021-2032) & (US$ Million) Figure 21. North America Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value (2021-2032) & (US$ Million) Figure 27. South America Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Coronary Pathway Assistive Instruments
  • Interventional Treatment Instruments
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Medtronic
  • OrbusNeich Medical Company
  • MicroPort Scientific Corporation
  • Suzhou Innomed Medical Device
  • Shunmei Medical
  • Shanghai INT Medical Instruments
  • Lepu Medical Technology
  • APT Medical
  • BrosMed Medical
  • Terumo Corporation
  • QualiMe
  • Merit Medical
  • Curatia Medical
  • Cordis
  • Cardionovum
  • Boston Scientific
  • ASAHI INTECC
  • Abbott
  • Zhejiang Barty Medical Technology
  • Shenzhen MicroApproach Medical Technology
  • Beijing Demax Medical Technology
  • JW Medical Systems
  • SINOMED
  • Kinhely Bio-Tech
  • Shandong Huaan Biotechnology
  • Blue Sail Medical
  • Shanghai Bio-heart Biological Technology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Dynamics
  1. 2.1 Percutaneous Coronary Intervention (PCI) Treatment Instruments Industry Trends
  2. 2.2 Percutaneous Coronary Intervention (PCI) Treatment Instruments Industry Drivers
  3. 2.3 Percutaneous Coronary Intervention (PCI) Treatment Instruments Industry Opportunities and Challenges
  4. 2.4 Percutaneous Coronary Intervention (PCI) Treatment Instruments Industry Restraints
3 Percutaneous Coronary Intervention (PCI) Treatment Instruments Market by Company
  1. 3.1 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Company Revenue Ranking in 2025
  2. 3.2 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Company (2021-2026)
  3. 3.3 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Company Ranking (2024-2026)
  4. 3.4 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Company Manufacturing Base and Headquarters
  5. 3.5 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Company Product Type and Application
  6. 3.6 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Percutaneous Coronary Intervention (PCI) Treatment Instruments Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Percutaneous Coronary Intervention (PCI) Treatment Instruments Market by Type
  1. 4.1 Percutaneous Coronary Intervention (PCI) Treatment Instruments Type Introduction
  2. 4.1.1 Coronary Pathway Assistive Instruments
  3. 4.1.2 Interventional Treatment Instruments
  4. 4.2 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value by Type
  5. 4.2.1 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value by Type (2021-2032)
  7. 4.2.3 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type (2021-2032)
5 Percutaneous Coronary Intervention (PCI) Treatment Instruments Market by Application
  1. 5.1 Percutaneous Coronary Intervention (PCI) Treatment Instruments Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value by Application
  6. 5.2.1 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value by Application (2021-2032)
  8. 5.2.3 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application (2021-2032)
6 Percutaneous Coronary Intervention (PCI) Treatment Instruments Regional Value Analysis
  1. 6.1 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value by Region (2021-2032)
  3. 6.2.1 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value by Region: 2021-2026
  4. 6.2.2 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value (2021-2032)
  7. 6.3.2 North America Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value (2021-2032)
  10. 6.4.2 Europe Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value (2021-2032)
  16. 6.6.2 South America Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Country, 2025 VS 2032
7 Percutaneous Coronary Intervention (PCI) Treatment Instruments Country-level Value Analysis
  1. 7.1 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value by Country (2021-2032)
  3. 7.2.1 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value by Country (2021-2026)
  4. 7.2.2 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Medtronic
  2. 8.1.1 Medtronic Company Information
  3. 8.1.2 Medtronic Business Overview
  4. 8.1.3 Medtronic Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Medtronic Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  6. 8.1.5 Medtronic Recent Developments
  7. 8.2 OrbusNeich Medical Company
  8. 8.2.1 OrbusNeich Medical Company Company Information
  9. 8.2.2 OrbusNeich Medical Company Business Overview
  10. 8.2.3 OrbusNeich Medical Company Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (2021-2026)
  11. 8.2.4 OrbusNeich Medical Company Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  12. 8.2.5 OrbusNeich Medical Company Recent Developments
  13. 8.3 MicroPort Scientific Corporation
  14. 8.3.1 MicroPort Scientific Corporation Company Information
  15. 8.3.2 MicroPort Scientific Corporation Business Overview
  16. 8.3.3 MicroPort Scientific Corporation Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (2021-2026)
  17. 8.3.4 MicroPort Scientific Corporation Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  18. 8.3.5 MicroPort Scientific Corporation Recent Developments
  19. 8.4 Suzhou Innomed Medical Device
  20. 8.4.1 Suzhou Innomed Medical Device Company Information
  21. 8.4.2 Suzhou Innomed Medical Device Business Overview
  22. 8.4.3 Suzhou Innomed Medical Device Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Suzhou Innomed Medical Device Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  24. 8.4.5 Suzhou Innomed Medical Device Recent Developments
  25. 8.5 Shunmei Medical
  26. 8.5.1 Shunmei Medical Company Information
  27. 8.5.2 Shunmei Medical Business Overview
  28. 8.5.3 Shunmei Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Shunmei Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  30. 8.5.5 Shunmei Medical Recent Developments
  31. 8.6 Shanghai INT Medical Instruments
  32. 8.6.1 Shanghai INT Medical Instruments Company Information
  33. 8.6.2 Shanghai INT Medical Instruments Business Overview
  34. 8.6.3 Shanghai INT Medical Instruments Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Shanghai INT Medical Instruments Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  36. 8.6.5 Shanghai INT Medical Instruments Recent Developments
  37. 8.7 Lepu Medical Technology
  38. 8.7.1 Lepu Medical Technology Company Information
  39. 8.7.2 Lepu Medical Technology Business Overview
  40. 8.7.3 Lepu Medical Technology Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Lepu Medical Technology Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  42. 8.7.5 Lepu Medical Technology Recent Developments
  43. 8.8 APT Medical
  44. 8.8.1 APT Medical Company Information
  45. 8.8.2 APT Medical Business Overview
  46. 8.8.3 APT Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (2021-2026)
  47. 8.8.4 APT Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  48. 8.8.5 APT Medical Recent Developments
  49. 8.9 BrosMed Medical
  50. 8.9.1 BrosMed Medical Company Information
  51. 8.9.2 BrosMed Medical Business Overview
  52. 8.9.3 BrosMed Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (2021-2026)
  53. 8.9.4 BrosMed Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  54. 8.9.5 BrosMed Medical Recent Developments
  55. 8.10 Terumo Corporation
  56. 8.10.1 Terumo Corporation Company Information
  57. 8.10.2 Terumo Corporation Business Overview
  58. 8.10.3 Terumo Corporation Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Terumo Corporation Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  60. 8.10.5 Terumo Corporation Recent Developments
  61. 8.11 QualiMe
  62. 8.11.1 QualiMe Company Information
  63. 8.11.2 QualiMe Business Overview
  64. 8.11.3 QualiMe Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (2021-2026)
  65. 8.11.4 QualiMe Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  66. 8.11.5 QualiMe Recent Developments
  67. 8.12 Merit Medical
  68. 8.12.1 Merit Medical Company Information
  69. 8.12.2 Merit Medical Business Overview
  70. 8.12.3 Merit Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Merit Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  72. 8.12.5 Merit Medical Recent Developments
  73. 8.13 Curatia Medical
  74. 8.13.1 Curatia Medical Company Information
  75. 8.13.2 Curatia Medical Business Overview
  76. 8.13.3 Curatia Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Curatia Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  78. 8.13.5 Curatia Medical Recent Developments
  79. 8.14 Cordis
  80. 8.14.1 Cordis Company Information
  81. 8.14.2 Cordis Business Overview
  82. 8.14.3 Cordis Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Cordis Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  84. 8.14.5 Cordis Recent Developments
  85. 8.15 Cardionovum
  86. 8.15.1 Cardionovum Company Information
  87. 8.15.2 Cardionovum Business Overview
  88. 8.15.3 Cardionovum Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Cardionovum Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  90. 8.15.5 Cardionovum Recent Developments
  91. 8.16 Boston Scientific
  92. 8.16.1 Boston Scientific Company Information
  93. 8.16.2 Boston Scientific Business Overview
  94. 8.16.3 Boston Scientific Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Boston Scientific Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  96. 8.16.5 Boston Scientific Recent Developments
  97. 8.17 ASAHI INTECC
  98. 8.17.1 ASAHI INTECC Company Information
  99. 8.17.2 ASAHI INTECC Business Overview
  100. 8.17.3 ASAHI INTECC Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (2021-2026)
  101. 8.17.4 ASAHI INTECC Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  102. 8.17.5 ASAHI INTECC Recent Developments
  103. 8.18 Abbott
  104. 8.18.1 Abbott Company Information
  105. 8.18.2 Abbott Business Overview
  106. 8.18.3 Abbott Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Abbott Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  108. 8.18.5 Abbott Recent Developments
  109. 8.19 Zhejiang Barty Medical Technology
  110. 8.19.1 Zhejiang Barty Medical Technology Company Information
  111. 8.19.2 Zhejiang Barty Medical Technology Business Overview
  112. 8.19.3 Zhejiang Barty Medical Technology Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Zhejiang Barty Medical Technology Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  114. 8.19.5 Zhejiang Barty Medical Technology Recent Developments
  115. 8.20 Shenzhen MicroApproach Medical Technology
  116. 8.20.1 Shenzhen MicroApproach Medical Technology Company Information
  117. 8.20.2 Shenzhen MicroApproach Medical Technology Business Overview
  118. 8.20.3 Shenzhen MicroApproach Medical Technology Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Shenzhen MicroApproach Medical Technology Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  120. 8.20.5 Shenzhen MicroApproach Medical Technology Recent Developments
  121. 8.21 Beijing Demax Medical Technology
  122. 8.21.1 Beijing Demax Medical Technology Company Information
  123. 8.21.2 Beijing Demax Medical Technology Business Overview
  124. 8.21.3 Beijing Demax Medical Technology Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Beijing Demax Medical Technology Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  126. 8.21.5 Beijing Demax Medical Technology Recent Developments
  127. 8.22 JW Medical Systems
  128. 8.22.1 JW Medical Systems Company Information
  129. 8.22.2 JW Medical Systems Business Overview
  130. 8.22.3 JW Medical Systems Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (2021-2026)
  131. 8.22.4 JW Medical Systems Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  132. 8.22.5 JW Medical Systems Recent Developments
  133. 8.23 SINOMED
  134. 8.23.1 SINOMED Company Information
  135. 8.23.2 SINOMED Business Overview
  136. 8.23.3 SINOMED Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (2021-2026)
  137. 8.23.4 SINOMED Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  138. 8.23.5 SINOMED Recent Developments
  139. 8.24 Kinhely Bio-Tech
  140. 8.24.1 Kinhely Bio-Tech Company Information
  141. 8.24.2 Kinhely Bio-Tech Business Overview
  142. 8.24.3 Kinhely Bio-Tech Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Kinhely Bio-Tech Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  144. 8.24.5 Kinhely Bio-Tech Recent Developments
  145. 8.25 Shandong Huaan Biotechnology
  146. 8.25.1 Shandong Huaan Biotechnology Company Information
  147. 8.25.2 Shandong Huaan Biotechnology Business Overview
  148. 8.25.3 Shandong Huaan Biotechnology Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (2021-2026)
  149. 8.25.4 Shandong Huaan Biotechnology Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  150. 8.25.5 Shandong Huaan Biotechnology Recent Developments
  151. 8.26 Blue Sail Medical
  152. 8.26.1 Blue Sail Medical Company Information
  153. 8.26.2 Blue Sail Medical Business Overview
  154. 8.26.3 Blue Sail Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (2021-2026)
  155. 8.26.4 Blue Sail Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  156. 8.26.5 Blue Sail Medical Recent Developments
  157. 8.27 Shanghai Bio-heart Biological Technology
  158. 8.27.1 Shanghai Bio-heart Biological Technology Company Information
  159. 8.27.2 Shanghai Bio-heart Biological Technology Business Overview
  160. 8.27.3 Shanghai Bio-heart Biological Technology Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (2021-2026)
  161. 8.27.4 Shanghai Bio-heart Biological Technology Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  162. 8.27.5 Shanghai Bio-heart Biological Technology Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst